ContextVision (CONTX.OL) Stock Price
ContextVision Price
Revenue has compounded at 4.0% per year over the past 19 years to 108.70 M SEK. Earnings per share have declined at 10.1% per year over the last 14 years. ContextVision's net margin stands at 0.7%, up from -7.8% several years earlier. ContextVision currently offers a dividend yield of about 10.30%. The payout ratio is around 108% of earnings. Analysts set a median price target of 4.20 SEK, implying 3.8% below the current price. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus. The stock trades about 59% above its 52-week low.
ContextVision stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of ContextVision over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how ContextVision stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing ContextVision's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | ContextVision Price |
|---|---|
| 9/2/2026 | 4.37 SEK |
| 9/1/2026 | 4.26 SEK |
| 8/31/2026 | 4.40 SEK |
| 8/28/2026 | 4.19 SEK |
| 8/27/2026 | 4.07 SEK |
| 8/26/2026 | 3.61 SEK |
| 8/25/2026 | 3.55 SEK |
| 8/24/2026 | 3.61 SEK |
| 8/21/2026 | 3.59 SEK |
| 8/20/2026 | 3.54 SEK |
| 8/19/2026 | 3.48 SEK |
| 8/18/2026 | 3.42 SEK |
| 8/17/2026 | 3.43 SEK |
| 8/14/2026 | 3.57 SEK |
| 8/13/2026 | 3.56 SEK |
| 8/12/2026 | 3.52 SEK |
| 8/11/2026 | 3.59 SEK |
| 8/10/2026 | 3.39 SEK |
| 8/7/2026 | 3.39 SEK |
| 8/6/2026 | 3.37 SEK |
| 8/5/2026 | 3.41 SEK |
| 8/4/2026 | 3.31 SEK |
| 7/31/2026 | 3.46 SEK |
| 7/30/2026 | 3.41 SEK |
| 7/29/2026 | 3.45 SEK |
| 7/28/2026 | 3.36 SEK |
| 7/27/2026 | 3.44 SEK |
| 7/24/2026 | 3.45 SEK |
| 7/23/2026 | 3.30 SEK |
| 7/22/2026 | 3.21 SEK |
ContextVision Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
ContextVision Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM SEK |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM SEK |
| EBITM SEK |
| EBIT MARGIN% |
| NET INCOMEM SEK |
| NET INCOME GROWTH% |
| DIVIDENDDIV.SEK |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60.00 | 63.00 | 71.00 | 80.00 | 79.00 | 89.00 | 93.00 | 93.00 | 96.00 | 116.00 | 130.00 | 128.00 | 108.00 | 107.00 | 109.00 | 111.00 |
| -9.09 | 5.00 | 12.70 | 12.68 | -1.25 | 12.66 | 4.49 | – | 3.23 | 20.83 | 12.07 | -1.54 | -15.63 | -0.93 | 1.87 | 1.83 |
| 96.67 | 96.83 | 97.18 | 97.50 | 97.47 | 97.75 | 97.85 | 97.85 | 97.92 | 97.41 | 97.69 | 97.66 | 97.22 | 97.22 | 97.22 | 97.22 |
| 58.00 | 61.00 | 69.00 | 78.00 | 77.00 | 87.00 | 91.00 | 91.00 | 94.00 | 113.00 | 127.00 | 125.00 | 105.00 | 104.03 | 105.97 | 107.92 |
| 6.00 | 6.00 | 6.00 | 5.00 | -1.00 | – | 19.00 | 15.00 | 43.00 | 40.00 | 43.00 | 29.00 | – | 29.00 | 30.00 | 30.00 |
| 10.00 | 9.52 | 8.45 | 6.25 | -1.27 | – | 20.43 | 16.13 | 44.79 | 34.48 | 33.08 | 22.66 | – | 27.10 | 27.52 | 27.03 |
| 4.00 | 5.00 | 5.00 | 4.00 | -1.00 | -1.00 | 7.00 | 11.00 | -7.00 | 28.00 | 32.00 | 24.00 | – | 11.00 | 12.00 | 12.00 |
| – | 25.00 | – | -20.00 | -125.00 | – | -800.00 | 57.14 | -163.64 | -500.00 | 14.29 | -25.00 | – | – | 9.09 | – |
| – | – | – | – | – | – | – | – | – | – | 0.45 | – | – | 0.54 | 0.65 | 0.78 |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 20.37 | 20.00 |
| 77.37 | 77.37 | 77.37 | 77.37 | 77.37 | 77.37 | 77.74 | 77.37 | 77.37 | 77.37 | 77.37 | 77.37 | 75.81 | 75.81 | 75.81 | 75.81 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales ContextVision generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue ContextVision retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare ContextVision's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares ContextVision has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against ContextVision's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
ContextVision stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
ContextVision Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
ContextVision business model & stock analysis
ContextVision SWOT Analysis
Strengths
- Advanced technology and expertise in medical imaging software solutions.
- Strong track record in delivering high-quality products to the market.
- Well-established reputation and trusted brand in the industry.
Weaknesses
- Relatively small market presence compared to larger competitors.
- Limited financial resources for extensive marketing and expansion.
- Dependence on a few key customers for significant revenue.
Opportunities
- Growing demand for advanced medical imaging technologies worldwide.
- Expansion into emerging markets with increasing healthcare needs.
- Potential collaborations or partnerships with major healthcare providers.
Threats
- Intense competition from larger, more established players in the market.
- Rapid technological advancements leading to the risk of obsolescence.
- Economic downturns impacting overall healthcare spending.
ContextVision Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
ContextVision historical P/E ratio, EBIT multiple, and P/S ratio
ContextVision annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
ContextVision shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
ContextVision stock splits
ContextVision Dividend History
2 years of dividend payments
ContextVision dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current ContextVision forecasts and price targets in September 2026
Analyst Price Targets 2026EESG©
Eulerpool ESG Scorecard© for the ContextVision stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
ContextVision shareholder structure
| % | Name |
|---|---|
2.63166% | |
1.11845% |
ContextVision Beneficial Ownership Filings (SEC 13D/G)
ContextVision Executives and Management Board
9 members · avg. age 64 · 11 % women
Mr. Gerald Potzsch (53)
Chief Executive Officer
3.44 M SEK
Management
Mr. Ola Lindblad
Chief Sales and Solution Officer · since 2023
Mr. Richard Hallstroem
Chief Financial Officer
Mr. Gunnar Laethen
Chief Technology Officer
Ms. Katarina Flood
Chief Service Officer
Board of Directors
Mr. Olof Sanden (63)
Independent Chairman of the Board
Mr. Sven Guenther-Hanssen (71)
Director · since 2011
Mr. Martin Hedlund (73)
Director · since 1997
Mr. Martin Ingvar (62)
Independent Director
Frequently asked questions about ContextVision
The business model of ContextVision AB is focused on providing advanced medical imaging software solutions. The company develops and sells state-of-the-art image enhancement technologies for use in various medical imaging applications. ContextVision's software algorithms are designed to enhance image quality, optimize accuracy, and improve workflow efficiency. By partnering with leading original equipment manufacturers (OEMs) in the medical imaging industry, ContextVision aims to deliver innovative solutions that enable healthcare providers to obtain clearer and more accurate medical images. With a strong emphasis on research and development, ContextVision continuously strives to maintain its position as a trusted provider of advanced imaging solutions to improve patient care and diagnosis.
ContextVision AB is primarily active in the medical imaging industry.
The main competitors of ContextVision AB in the market include companies such as GE Healthcare, Siemens Healthineers, and Merge Healthcare. These companies also operate in the medical imaging and artificial intelligence software sectors, offering similar products and solutions. ContextVision AB strives to distinguish itself through its innovative technologies and advanced image enhancement solutions, ensuring enhanced image quality and accurate diagnoses for healthcare professionals. With a strong focus on research and development, ContextVision AB continuously aims to stay ahead of the competition and deliver cutting-edge software solutions to meet the evolving needs of the medical imaging industry.
ContextVision AB is a renowned company specializing in medical imaging software solutions. Established in 1983, the company has amassed a rich history and background in the medical technology domain. ContextVision AB focuses on developing innovative software, such as image enhancement, 3D visualization, and AI-based technologies, catering to healthcare providers and medical imaging equipment manufacturers globally. With its strong industry expertise and continuous research and development efforts, ContextVision AB has positioned itself as a leading provider of state-of-the-art imaging solutions. The company's dedication to quality and customer satisfaction has earned it a reputable name in the medical imaging industry.
ContextVision AB has successfully achieved several significant milestones over the years. Some noteworthy accomplishments include developing innovative software solutions for medical imaging, establishing strong partnerships with leading industry players, and receiving numerous prestigious awards for their cutting-edge technologies. Additionally, ContextVision AB has consistently demonstrated strong financial performance and growth, consolidating its position as a key player in the medical imaging market. These milestones highlight the company's commitment to innovation, excellence, and delivering value to its customers. ContextVision AB's achievements emphasize its reputation as a reliable and forward-thinking company in the field of medical imaging.
ContextVision AB is primarily present in several countries and regions. It has a strong presence in Europe, with a focus on Scandinavian countries such as Sweden, Norway, and Finland. The company also operates in other European regions including Germany and the United Kingdom. In addition to Europe, ContextVision AB has expanded its presence in the Asia-Pacific region, particularly in China and Japan. Furthermore, the company has a growing customer base in North America, particularly in the United States and Canada. ContextVision AB's global footprint allows it to cater to a wide range of customers and provide its innovative stock services worldwide.
ContextVision AB represents a strong set of values and corporate philosophy. The company is committed to delivering high-quality medical imaging software solutions to healthcare providers worldwide. ContextVision AB prioritizes innovation, collaboration, and customer satisfaction. With a strong focus on research and development, ContextVision AB continuously strives to enhance patient care and improve outcomes. By leveraging cutting-edge technology and expertise, the company aims to provide efficient and reliable solutions for medical image analysis and enhancement. ContextVision AB's commitment to excellence and customer-centric approach make it a trusted leader in the healthcare technology industry.
Analysts currently set an average price target of 4.20 SEK for the ContextVision stock (median: 4.20 SEK), implying -3.8 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the ContextVision stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect ContextVision to generate revenue of 107.43 M SEK and earnings per share of 0.15 SEK.
Converted at the current exchange rate, the ContextVision share trades at 0.39 EUR (4.37 SEK).
The ContextVision share (CONTX.OL) is listed on 3 stock exchanges, including: London (0L8Z.L), London (0L8Z.L).
ContextVision AB is a leading provider of innovative solutions in the field of medical imaging. The company was founded in 1983 and currently employs over 100 employees. It has been listed on the Nasdaq Stockholm since 1999 and is headquartered in Stockholm, Sweden. ContextVision consists of four business areas that focus on specific segments of medical imaging: digital pathology, ultrasound, mammography, and radiography. Each business area offers a wide range of products and services aimed at improving precision, efficiency, and patient care. The product portfolio of ContextVision is tailored to the needs of medical professionals and clinicians who rely on accurate analysis and diagnosis of images. For example, the company offers a state-of-the-art software platform for digital pathology, allowing pathologists to digitally capture, store, and analyze histological images and data. This improves the accuracy of diagnosis and increases efficiency in pathology laboratories. Another example is the company's ultrasound division, which focuses on improving image quality and precision in ultrasound diagnostics. Through its image enhancement technology, ContextVision provides more productive diagnostic solutions that are faster and more accurate than conventional ultrasound systems. The company also offers solutions for mammography that target the detection of smaller tumors. Together, these offerings not only improve patient care but also contribute to reducing medical errors. ContextVision gains market share through partnerships with leading manufacturers of medical imaging devices. The company leverages its unique expertise in image analysis and enhancement to develop innovative solutions in collaboration with its partners. This collaboration has, for example, led to the development of the "GOPiCE" concept, which represents a benchmark in digital pathology. The range of solutions allows customers to create more efficient diagnoses while ensuring higher accuracy and reliability in patient care. Overall, ContextVision has secured its leading position in the field of medical imaging through the continuity of its performance and its willingness to adapt to the needs of its customers and partners. The company is committed to improving medical imaging and supporting its customers through innovative solutions. ContextVision is a pioneer in image analysis and an important component in the medical field.
The expected revenue of ContextVision is 107.43 M SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of ContextVision is 11.51 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of ContextVision is currently 28.77. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the ContextVision stock.
The price-to-sales ratio (P/S) of ContextVision is currently 3.08. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the ContextVision stock.
The Eulerpool Quality Score for ContextVision is 1/10.
The ISIN of ContextVision is SE0014731154. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of ContextVision is A2QA6S. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of ContextVision is CONTX.OL. The ticker symbol is used to trade ContextVision shares on the stock exchange.
Over the past 12 months, ContextVision paid a dividend of 0.45 SEK . This corresponds to a dividend yield of about 10.30 %. For the coming 12 months, ContextVision is expected to pay a dividend of 0.65 SEK.
The current dividend yield of ContextVision is 10.30 %.
ContextVision pays a dividend, distributed in the months of , , , .
ContextVision paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0.65 SEK are expected. This corresponds to a dividend yield of 14.83 %.
ContextVision is assigned to the 'Health' sector.
To receive the latest dividend of ContextVision from amounting to 0.15 SEK, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
The dividends of ContextVision are distributed in SEK.
ContextVision stock
ContextVision Peer Group
ContextVision Ticker
ContextVision FIGI
All fundamentals and in-depth analysis of ContextVision
Our stock analysis for ContextVision stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ContextVision. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.